In the cohort for proteomic analysis, compared with those without sarcopenia, individuals with sarcopenia exhibited older age, higher inflammatory levels, higher aCCI, and higher number of drugs, which could influence IGFBP2 expression level. Here, IGFBP2 is linked to sarcopenia.